Gottbetter & Partners is a Gold Sponsor for the 2nd Annual Marcum MicroCap Conference to be held at the Grand Hyatt Hotel in New York City on May 30th. This one day investor conference is hosted by Marcum LLP, one of the top ten auditors of U.S. public companies.
Adam Gottbetter, Managing Partner of Gottbetter & Partners will participate on the panel "Evaluating Pre Approval and Pre Revenue Life Science Companies" at the conference. This panel will discuss the importance of understanding the core science or technology, history and experience of the CEO and management team, it will analyze expenditures and burn - administrative vs. scientific, and will look at the depth of a company's IP, probability of post approval adoption and other concerns.
The Marcum MicroCap Conference is dedicated to introducing investors to the very best, undiscovered companies under $500 million in market capitalization. The Conference is expected to draw more than 1,000 attendees including senior personnel from almost 100 presenting public companies, leading institutional investors, directors, bankers and service providers to the microcap marketplace.
Gottbetter & Partners LLP Sponsored the Inaugural Marcum MicroCap Conference on June 20th in NYC
Gottbetter & Partners, was a Gold Sponsor for the Inaugural Marcum MicroCap Conference held at the Roosevelt Hotel in New York City on June 20th. This one day investor conference was hosted by Marcum LLP, one of the top ten auditors of U.S. public companies.
The Marcum MicroCap conference designed for investors interested in the micro-cap arena, attracted over 500 participants, including institutional investors, mutual funds, hedge funds, wealth managers, and family offices. The event will feature presentation tracks highlighting the hottest growth sectors as well as panels on subjects highly relevant to small-cap corporate finance.
Adam Gottbetter, Managing Partner of Gottbetter & Partners participated on the thought leadership panel at the conference regarding the State of Micro-cap Finance: Deal Terms & Structures from the Front Lines.
IRS Circular 230 Disclosure: To ensure compliance with requirements imposed by the IRS, we inform you that any U.S. federal tax advice contained in this communication (including any attachments) is not intended or written to be used, and cannot be used, for the purpose of (i) avoiding penalties under the Internal Revenue Code or (ii) promoting, marketing or recommending to another party any transaction or matter addressed herein. If you are not the original addressee of this communication, you should seek advice based on your particular circumstances from an independent advisor
Adam Gottbetter moderated a panel at The PIPEs Conference titled "How the 'Attack' on Reverse Mergers Might Affect Small Company Capital Formation." The discussion gauged the possible impact on the marketplace for small companies looking at APOs as the path to going public. Panelists dissected how recent news might have an effect going forward and to ensure that the information that investors receive is valid. Specifically the problems associated with Chinese reverse mergers and their underlying audits resulted in a failure by professionals, investors and regulators to demand the same level of standards for high demand Chinese deals as they would normally for other type of deals. In spite of the drop in Chinese reverse mergers the panelists indicated they are busy with APOs and the Canadian market seems to be unaffected by the Chinese scandal. The investors leading many APOs are retail investors with institutional investors filling out deals or leading follow-on financings. To insure that the APO market remains vibrant and credible, the panelists recommended that deal makers work with experienced and reputable professionals and vendors and to ask for references. On the regulatory front, there was discussion about the proposed SEC rule requiring "seasoning" of companies that complete APOs with a "shell" company before making application to NYSE, AMEX or NASDAQ. The practitioners felt it would not have a practical effect because many post APO companies need time to mature, build the requisite shareholder base and stock price not to mention desire for exchanges to see a 10-K filing before granting approval. Lastly, the panelists took questions on a variety of the issues covered by the panel.
Adam Gottbetter moderated a panel discussion titled "Reverse Mergers: Still an Assured Route to the Public Markets? Why Reverse Mergers Remain a Cost-effective (and Efficient) Path to Getting Public". The panel discussed APO deal flow and the trend in deal size; the appetite for institutional and retail investors for such deals including the perspective of placement agents. The panel dismissed the concept that investment dollars were down for APOs because of the structure since investment was down for IPOs and PIPEs as well. As the discussion of China deals, and the related failures, dominated the Conference in general, the panel gave their views on the drop in those deals and its impact on APOs in general as well as the rise in APOs in other foreign markets like Canada. Finally, Adam and the panel discussed the emergence of alternative US over the counter markets.
The Reverse Merger Conference returned to Los Angeles. This is the premier event for serious professionals in the business of alternative IPO transactions. The conference, in its 7th year, is the largest educational and networking event in the business. The two-day event featured technical training on the latest issues relating to reverse mergers, self-underwriting, and other alternative routes to the public market.